UnitedHealth Group (UNH) Stock Forecast & Price Target

$569.80

+10.12 (+1.81%)

(As of 07/26/2024 ET)

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 20 Analyst Ratings

Based on 20 Wall Street analysts who have issued ratings for UnitedHealth Group in the last 12 months, the stock has a consensus rating of "Buy." Out of the 20 analysts, 1 has given a hold rating, 18 have given a buy rating, and 1 has given a strong buy rating for UNH.

Consensus Price Target

$614.17
7.79% Upside

High Forecast	$680.00
Average Forecast	$614.17
Low Forecast	$559.00

According to the 20 analysts' twelve-month price targets for UnitedHealth Group, the average price target is $614.17. The highest price target for UNH is $680.00, while the lowest price target for UNH is $559.00. The average price target represents a forecasted upside of 7.79% from the current price of $569.80.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Buy	Moderate Buy	Moderate Buy	Buy
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	18 Buy rating(s)	17 Buy rating(s)	15 Buy rating(s)	14 Buy rating(s)
Hold	1 Hold rating(s)	2 Hold rating(s)	3 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$614.17	$579.74	$570.05	$579.89
Forecasted Upside	7.79% Upside	18.45% Upside	17.52% Upside	17.88% Upside

Get UnitedHealth Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for UNH and its competitors with MarketBeat's FREE daily newsletter.

Ad Unstoppable Prosperity

“Generational Bull Run” Incoming

LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.

You can find out what they are by clicking here now.

UNH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

UNH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

UnitedHealth Group Stock vs. The Competition

Type	UnitedHealth Group	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.72	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	7.79% Upside	3,121.53% Upside	9.09% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/23/2024	Cantor Fitzgerald 3 of 5 stars		Reiterated Rating	Overweight ➝ Overweight	$591.00 ➝ $591.00	+6.20%
7/18/2024	HSBC 2 of 5 stars		Boost Target		$580.00 ➝ $610.00	+7.68%
7/18/2024	UBS Group 4 of 5 stars		Boost Target	Buy ➝ Buy	$640.00 ➝ $680.00	+20.90%
7/17/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Toung Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$570.00 ➝ $600.00	+4.95%
7/17/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$546.00 ➝ $601.00	+5.51%
7/17/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$560.00 ➝ $604.00	+6.30%
Get the Latest News and Ratings for UNH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors with MarketBeat's FREE daily newsletter.
7/17/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$525.00 ➝ $630.00	+11.23%
7/17/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$555.00 ➝ $615.00	+8.86%
7/17/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$595.00 ➝ $615.00	+12.05%
7/17/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$597.00 ➝ $640.00	+16.60%
7/17/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$600.00 ➝ $640.00	+16.60%
7/17/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$481.00 ➝ $647.00	+17.88%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/30/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$546.00 ➝ $559.00	+15.75%
4/19/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$545.00 ➝ $562.00	+13.96%
4/17/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$566.00 ➝ $571.00	+18.76%
3/13/2024	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
3/7/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$675.00	+42.83%
2/8/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$605.00	+16.37%
1/17/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$610.00	+15.23%
7/18/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$595.00 ➝ $603.00	+24.55%
7/11/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$600.00 ➝ $549.00	+18.56%
6/14/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$625.00 ➝ $560.00	+13.98%
4/17/2023	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$590.00 ➝ $600.00	+17.24%
4/14/2023	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Strong-Buy	$630.00	+24.75%
12/7/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$590.00 ➝ $610.00	+13.11%
10/17/2022	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$625.00 ➝ $618.00	+20.44%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:34 AM ET.

UNH Forecast - Frequently Asked Questions

What is UnitedHealth Group's forecast for 2024?: According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for UnitedHealth Group is $614.17, with a high forecast of $680.00 and a low forecast of $559.00.
Should I buy or sell UnitedHealth Group stock right now?: 20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last year. There is currently 1 hold rating, 18 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" UNH shares.
Does UnitedHealth Group's stock price have much upside?: According to analysts, UnitedHealth Group's stock has a predicted upside of 14.32% based on their 12-month stock forecasts.
Has UnitedHealth Group been upgraded by Wall Street analysts recently?: Over the previous 90 days, UnitedHealth Group's stock had 3 upgrades by analysts.
What analysts cover UnitedHealth Group?: UnitedHealth Group has been rated by research analysts at Argus, Baird R W, Barclays, Cantor Fitzgerald, HSBC, Jefferies Financial Group, JPMorgan Chase & Co., Morgan Stanley, Robert W. Baird, Royal Bank of Canada, TD Cowen, Truist Financial, UBS Group, and Wells Fargo & Company in the past 90 days.
Do Wall Street analysts like UnitedHealth Group more than its competitors?: Analysts like UnitedHealth Group more than other "medical" companies. The consensus rating for UnitedHealth Group is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how UNH compares to other companies.